Parameter
| Biomarker | DRAM1 mRNA, ARSA mRNA | Full name | DNA Damage-Regulated Autophagy Modulator 1 mRNA, Arylsulfatase A mRNA | Molecular Type | Nucleic acid（RNA） |
|---|---|---|---|---|---|
| Molecular Formula | / | Molecular Weight | / | Core Functional Dimensions | Diagnosis, Monitoring |
| Disease | Pleural Mesothelioma | Disease Subtypes | / | ||
| Organ | pleura | Test Sample / Technology Platform | Serum (specific technology platform not specified) | ||
| Pathobiological Mechanisms | Abnormal levels of expression in PM may be related to pathways involved in tumorigenesis and development | ||||
| Clinical Availability Status | Frontier research stage: Expression in serum is related to PM, and it is included in potential marker studies | ||||
| Notes and Dynamics | It belongs to the research category of PM serum biomarkers, and its clinical application value needs to be further confirmed | ||||